Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
TP53 (Tumor protein P53)
i
Other names:
TP53, Tumor Protein P53, Cellular Tumor Antigen P53, Phosphoprotein P53, Tumor Protein P53, Antigen NY-CO-13, Transformation-Related Protein 53, Mutant Tumor Protein 53, P53 Tumor Suppressor, Tumor Suppressor P53, Tumor Protein 53, BMFS5, TRP53, BCC7, LFS1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
7157
Related tests:
‹
Guardant360® CDx (54)
FoundationOne® Liquid CDx (21)
MSK-IMPACT (21)
FoundationOne® Heme CDx (10)
TruSight Oncology 500 Assay (3)
Guardant360 TissueNext™ (2)
UW-Oncoplex™ (2)
Vysis CLL FISH Probe Kit (2)
Tempus xT Assay (1)
AML Express™
AVENIO Tumor Tissue Expanded Kit
AVENIO Tumor Tissue Surveillance Kit
AVENIO Tumor Tissue Targeted Kit
AVENIO ctDNA Expanded Kit
AVENIO ctDNA Surveillance Kit
AVENIO ctDNA Targeted Kit
Altera
AmoyDx® HANDLE Classic NGS Panel
AmoyDx® HANDLE HRR NGS Panel
AmoyDx® HRD Complete Panel
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
AnchorAIM® Personalized Treatment of Colorectal Cancer 11 Gene Test
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Myeloid panel
Archer® VariantPlex® Solid Tumor Kit
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer™ VARIANTPlex™ Pan Solid Tumor panel
BRCANext®
BRCAplus®
BRCAvantage™ Plus
BROCA Cancer Risk Panel
Blueprint Genetics Comprehensive Hereditary Cancer Panel
BrainTumorNext®
BreastNext®
CNV+ Breast Cancer NGS Panel
CONFIRM anti-p53 (DO-7) Primary Antibody
CancerNext ®
CancerNext-Expanded®
ColoNext®
ColoSeq™
CustomNext-Cancer®
Devyser HBOC NGS
EarlyCDT®-Lung
Empower™ Hereditary cancer test
Find It®
Follow It®
GALEAS™ Hereditary Plus
GYNplus®
GenomicsNext™ Liquid Biopsy
InVisionSeq™
Invitae Common Hereditary Cancers Panel
Ion AmpliSeq Colon and Lung Cancer Research Panel v2
LiquidGx™
LiquidHALLMARK®
LiquidPlex™
Mammostrat® Breast Cancer Recurrence Assay
MelanomaNext®
Myeloid Molecular Profile
Myriad myRisk® Hereditary Cancer
NGS Targeted Hotspot Panel
NeoLAB® Solid Tumor Liquid Biopsy
NeoTYPE® Lung Tumor Profile
Northstar Select™
NovoFocus™ CRC 2.0
NovoFocus™ NSCLC 2.0 Test
NovoFocus™ PARPi CDx
OncoFOLLOW
OncoGuide™ NCC Oncopanel System
OncoKey™ SL 60 Plus Assay
OncoPanel™ Assay
OncoScan™ CNV Plus Assay
Oncomine Lung Cell-Free Total Nucleic Acid Research Assay
Oncomine Myeloid Assay GX
Oncomine Precision Assay
Oncomine Solid Tumor DNA Kit
Oncomine Tumor Mutation Load Assay
Oncomine™ Breast cfDNA Assay
Oncomine™ Colon cfDNA Assay
Oncomine™ Lung cfDNA Assay
Oncomine™ Myeloid MRD Assays
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
OvaNext®
P53 (TP53) Deletion FISH Probe Kit
PGDx elio™ plasma resolve assay
PancNext®
PredicineCARE™
ProstateNext®
QVantageᵀᴹ
RenalNext™
SOPHiA DDM HRD Solution
SOPHiA DDM™ Myeloid Solution
SOPHiA DDM™ Solid Tumor Plus Solution
SOPHiA Myeloid Plus Solution
SafeSEQ AML MRD Assay
SafeSEQ CRC MRD assay
SafeSEQ HNSCC assay
StrataNGS™ Test
SureSeq CLL + CNV V3 NGS Panel
SureSeq™ CLL + CNV Panel
SureSeq™ Myeloid MRD Panel
SureSeq™ Pan-Myeloid Panel
Target Selector™ NGS Lung Panel
Tempus xF Assay
Tempus xG+
TruSight Myeloid Sequencing Panel
TruSight Oncology Comprehensive
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
VarMap™ Pan-Cancer NGS Panel
oncoReveal™ Core LBx
oncoReveal™ Essential LBx
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
Guardant360® CDx (54)
FoundationOne® Liquid CDx (21)
MSK-IMPACT (21)
FoundationOne® Heme CDx (10)
TruSight Oncology 500 Assay (3)
Guardant360 TissueNext™ (2)
UW-Oncoplex™ (2)
Vysis CLL FISH Probe Kit (2)
Tempus xT Assay (1)
AML Express™
AVENIO Tumor Tissue Expanded Kit
AVENIO Tumor Tissue Surveillance Kit
AVENIO Tumor Tissue Targeted Kit
AVENIO ctDNA Expanded Kit
AVENIO ctDNA Surveillance Kit
AVENIO ctDNA Targeted Kit
Altera
AmoyDx® HANDLE Classic NGS Panel
AmoyDx® HANDLE HRR NGS Panel
AmoyDx® HRD Complete Panel
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
AnchorAIM® Personalized Treatment of Colorectal Cancer 11 Gene Test
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Myeloid panel
Archer® VariantPlex® Solid Tumor Kit
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer™ VARIANTPlex™ Pan Solid Tumor panel
BRCANext®
BRCAplus®
BRCAvantage™ Plus
BROCA Cancer Risk Panel
Blueprint Genetics Comprehensive Hereditary Cancer Panel
BrainTumorNext®
BreastNext®
CNV+ Breast Cancer NGS Panel
CONFIRM anti-p53 (DO-7) Primary Antibody
CancerNext ®
CancerNext-Expanded®
ColoNext®
ColoSeq™
CustomNext-Cancer®
Devyser HBOC NGS
EarlyCDT®-Lung
Empower™ Hereditary cancer test
Find It®
Follow It®
GALEAS™ Hereditary Plus
GYNplus®
GenomicsNext™ Liquid Biopsy
InVisionSeq™
Invitae Common Hereditary Cancers Panel
Ion AmpliSeq Colon and Lung Cancer Research Panel v2
LiquidGx™
LiquidHALLMARK®
LiquidPlex™
Mammostrat® Breast Cancer Recurrence Assay
MelanomaNext®
Myeloid Molecular Profile
Myriad myRisk® Hereditary Cancer
NGS Targeted Hotspot Panel
NeoLAB® Solid Tumor Liquid Biopsy
NeoTYPE® Lung Tumor Profile
Northstar Select™
NovoFocus™ CRC 2.0
NovoFocus™ NSCLC 2.0 Test
NovoFocus™ PARPi CDx
OncoFOLLOW
OncoGuide™ NCC Oncopanel System
OncoKey™ SL 60 Plus Assay
OncoPanel™ Assay
OncoScan™ CNV Plus Assay
Oncomine Lung Cell-Free Total Nucleic Acid Research Assay
Oncomine Myeloid Assay GX
Oncomine Precision Assay
Oncomine Solid Tumor DNA Kit
Oncomine Tumor Mutation Load Assay
Oncomine™ Breast cfDNA Assay
Oncomine™ Colon cfDNA Assay
Oncomine™ Lung cfDNA Assay
Oncomine™ Myeloid MRD Assays
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
OvaNext®
P53 (TP53) Deletion FISH Probe Kit
PGDx elio™ plasma resolve assay
PancNext®
PredicineCARE™
ProstateNext®
QVantageᵀᴹ
RenalNext™
SOPHiA DDM HRD Solution
SOPHiA DDM™ Myeloid Solution
SOPHiA DDM™ Solid Tumor Plus Solution
SOPHiA Myeloid Plus Solution
SafeSEQ AML MRD Assay
SafeSEQ CRC MRD assay
SafeSEQ HNSCC assay
StrataNGS™ Test
SureSeq CLL + CNV V3 NGS Panel
SureSeq™ CLL + CNV Panel
SureSeq™ Myeloid MRD Panel
SureSeq™ Pan-Myeloid Panel
Target Selector™ NGS Lung Panel
Tempus xF Assay
Tempus xG+
TruSight Myeloid Sequencing Panel
TruSight Oncology Comprehensive
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
VarMap™ Pan-Cancer NGS Panel
oncoReveal™ Core LBx
oncoReveal™ Essential LBx
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
›
Associations
(644)
News
Trials
VERI cancer hierarchy
Reset Filters
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
venetoclax + obinutuzumab
Sensitive: A1 - Approval
venetoclax + obinutuzumab
Sensitive
:
A1
venetoclax + obinutuzumab
Sensitive: A1 - Approval
venetoclax + obinutuzumab
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
venetoclax
Sensitive: A1 - Approval
venetoclax
Sensitive
:
A1
venetoclax
Sensitive: A1 - Approval
venetoclax
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
rituximab + idelalisib
Sensitive: A1 - Approval
rituximab + idelalisib
Sensitive
:
A1
rituximab + idelalisib
Sensitive: A1 - Approval
rituximab + idelalisib
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
acalabrutinib
Sensitive: A1 - Approval
acalabrutinib
Sensitive
:
A1
acalabrutinib
Sensitive: A1 - Approval
acalabrutinib
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
idelalisib + ofatumumab
Sensitive: A1 - Approval
idelalisib + ofatumumab
Sensitive
:
A1
idelalisib + ofatumumab
Sensitive: A1 - Approval
idelalisib + ofatumumab
Sensitive
:
A1
TP53 wild-type
Small Lymphocytic Lymphoma
TP53 wild-type
Small Lymphocytic Lymphoma
PCR
Sensitive: A2 - Guideline
PCR
Sensitive
:
A2
PCR
Sensitive: A2 - Guideline
PCR
Sensitive
:
A2
TP53 wild-type
Small Lymphocytic Lymphoma
TP53 wild-type
Small Lymphocytic Lymphoma
FCR
Sensitive: A2 - Guideline
FCR
Sensitive
:
A2
FCR
Sensitive: A2 - Guideline
FCR
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
rituximab + alemtuzumab
Sensitive: A2 - Guideline
rituximab + alemtuzumab
Sensitive
:
A2
rituximab + alemtuzumab
Sensitive: A2 - Guideline
rituximab + alemtuzumab
Sensitive
:
A2
TP53 wild-type
Small Lymphocytic Lymphoma
TP53 wild-type
Small Lymphocytic Lymphoma
alemtuzumab
Sensitive: A2 - Guideline
alemtuzumab
Sensitive
:
A2
alemtuzumab
Sensitive: A2 - Guideline
alemtuzumab
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
venetoclax + rituximab
Sensitive: A2 - Guideline
venetoclax + rituximab
Sensitive
:
A2
venetoclax + rituximab
Sensitive: A2 - Guideline
venetoclax + rituximab
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.